PAPER
Preparation of a,a-Disubstituted Trifluoromethyl Ketones
841
3
3
2JC-F = 29 Hz, CF3C=C), 138.9, 139.8, 141.1 (q, JC-F = 3 Hz,
(q, 2JC-F = 29 Hz, CF3C=C), 137.2, 137.5, 141.4 (q, JC-F = 3.6 Hz,
CF3C=C).
CF3C=C).
Anal. calcd for C23H20F3NO (383.4): C, 72.05; H, 5.26; N, 3.65.
Found: C, 71.67; H, 5.31; N, 3.61.
Anal. calcd for C23H24F3NO (387.4): C, 71.30; H, 6.24; N, 3.62.
Found: C, 71.90; H, 6.19; N, 3.55.
(E,E/Z,E)-4-Morpholino-1,3-diphenyl-5,5,5-trifluoropenta-1,3-
diene (12d)
(Z/E)-1-Naphthyl-1-phenyl-2-piperidino-3,3,3-trifluoroprop-1-
ene (14c)
19F NMR: d = -55.5 (s) (E,E)/-58.6 (s) (Z,E) (70:30).
19F NMR: d = -58.8 (Z)/-58.9 (E) (70:30) (s, CF3).
1H NMR: d = 2.6 (Z,E)/3.1 (E,E) (t, J = 4.3 Hz, 4 H), 3.4 (Z,E)/3.9
(E,E) (t, J = 4.6 Hz, 4 H), 6.1 (E,E)/6.2 (Z,E) (d, J = 16 Hz, 1 H),
7.1-7.5 (m, 10 H), 7.8 (d, J = 16 Hz, 1 H).
1H NMR: d = 1.5 (m, 6 H, 3 CH2), 2.8 (m, 4 H, 2 CH2), 7.0-8.1 (m,
12 H).
13C NMR: d = 24.0 (Z)/24.1(E), 26.5 (Z)/26.6 (E), 53.8 (Z)/53.9 (E),
13C NMR: d = 51.5 (E,E)/52.0 (Z,E), 67.2 (Z,E)/67.8 (E,E), 123.5
126.1-128.3, 129.5, 132.5, 132.9, 136.8 (q, JC-F = 29 Hz,
2
1
(q, JC-F = 280 Hz, CF3), 126.4, 127.9, 128.3, 128.5, 128.7, 128.8,
CF3C=C), 137.7, 140.2. CF3 (not observed)
129.1 (q, 5JC-F = 2.0 Hz), 134.0 (q, 2JC-F = 28 Hz, CF3C=C), 136.0,
136.9, 142.1 (q, 3JC-F = 3.6 Hz, CF3C=C).
3-(4-Fluorophenyl)-3-phenyl-1,1,1-trifluoropropan-2-one
(15a); Typical Procedure
Anal. calcd for C21H20F3NO (359.4): C, 70.18; H, 5.61, N, 3.90.
Found: C, 70.88, H, 5.40; N, 3.58.
To a solution of enamine 12a (200 mg, 0.57 mmol) in MeCN (5 mL)
was added 3 N HCl (0.38 mL, 1.1 mmol). After 15 min at reflux of
the solvent, the mixture was neutralized with aq 1 N NaHCO3 solu-
tion (1.1 mL). The organic phase was extracted with Et2O (3 × 10
mL). The combined organic phases were dried (MgSO4) and con-
centrated to give crude ketone 15a (140 mg, 87%).
(Z/E)-3-(4-Fluorophenyl)-2-morpholino-5-phenyl-1,1,1-tri-
fluoropent-2-ene (13a)
19F NMR: d = -54.8 (E)/-59.0 (Z) (10:90) (s, CF3), -114.5 (E)/
-116.0 (Z) (10/90) (m, C6H4F).
1H NMR: d = 2.5(Z)/2.9 (m, 4 H), 2.6 (m, 4 H), 3.4 (Z)/3.7 (m, 4 H),
6.9-7.3 (m, 9 H).
19F NMR: d = -77.3 (s, CF3), -114.0 (m, C6H4F).
1H NMR: d = 5.6 (s, 1 H), 6.9-7.5 (m, 10 H).
13C NMR: d = 33.3/34.7 (Z), 35.9 (Z)/37.1, 51.0/51.8 (Z), 67.2 (Z)/
2
1
13C NMR: d = 57.1, 116.0 (d, JC-F = 22 Hz), 116.1 (q, JC-F = 293
2
1
67.6, 115.4 (d, JC-F = 21.7 Hz, CHCF), 123.5 (q, JC-F = 281 Hz,
3
CF3), 126.2, 128.3, 128.4, 129.7 (d, 3JC-F = 7.3 Hz, CHCF), 135.3 (q,
HZ, CF3), 128.3, 128.8, 129.2, 130.5 (d, JC-F = 8.5 Hz), 131.5 (d,
4JC-F = 3.0 Hz), 135.4, 162.6 (d, 1JC-F = 247 Hz), 149.9 (q, 2JC-F = 34
Hz, CF3CO).
2JC-F = 29 Hz, CF3C=C), 136.4 (d, JC-F = 3.8 Hz, CCF), 141.1,
4
143.2 (q, 4JC-F = 2.2 Hz, CF3C=C), 162.5 (d, 1JC-F = 247 Hz, CHCF).
IR (CH2Cl2): nC=O = 1756 cm-1.
Anal. calcd for C21H21F4NO (379.4): C, 66.48; H, 5.58; N, 3.69.
Found: C, 66.46; H, 5.60; N, 3.58.
3-(4-Methoxyphenyl)-3-phenyl-1,1,1-trifluoropropan-2-one
(15b)
(Z/E)-3-(4-Methoxyphenyl)-2-morpholino-5-phenyl-1,1,1-tri-
fluoropent-2-ene (13b)
19F NMR: d = -77.3 (s, CF3).
19F NMR: d = -54.8 (E)/-59.4 (Z) (10:90) (s, CF3).
1H NMR: d = 3.8 (s, 3 H), 5.5 (s, 1 H), 6.8-7.5 (m, 9 H).
1H NMR: d = 2.5 (Z)/2.9 (m, 4 H), 2.65 (m, 4 H), 3.5 (Z)/3.75 (m, 4
H), 3.8 (s, OCH3), 6.7-7.4 (m, 9 H).
13C NMR: d = 55.2, 57.2, 114.6, 116.1 (q, JC-F = 293 Hz, CF3),
1
127.4, 128.1, 128.8, 129.0, 130.1, 136.1, 159.5, 190.2 (q, 2JC-F = 33
Hz, CF3CO).
13C NMR: d = 33.4/34.9 (Z), 36.2 (Z)/37.2, 51.1/52.6 (Z), 55.3, 67.3
1
IR (CH2Cl2): nC=O = 1729 cm-1.
(Z)/67.7, 113.5/113.7 (Z), 124.3 (q, JC-F = 281 Hz, CF3), 126.0,
2
128.3, 128.4, 129.3, 132.5, 134.5 (q, JC-F = 29 Hz, CF3-C=C),
3-Naphthyl-3-phenyl-1,1,1-trifluoropropan-2-one (15c)
141.5, 143.1 (q, 3JC-F = 1.8 Hz, CF3C=C), 159.1.
19F NMR: d = -77.4 (s, CF3).
Anal. calcd for C22H24F3NO2 (391.4): C, 67.51; H, 6.18; N, 3.58.
Found: C, 67.51; H, 6.26; N, 3.51.
1H NMR: d = 5.7 (s, 1 H), 7.2-8.2 (m, 12 H).
13C NMR: d = 58.0, 116.2 (q, 1JC-F = 293, CF3), 125.8-129.1, 132.9,
(Z/E)-2-Morpholino-3-naphthyl-5-phenyl-1,1,1-trifluoropent-
2-ene (13c)
133.0, 133.4, 138.5, 189.6 (q, 2JC-F = 34, CF3CO).
IR (CH2Cl2): nC=O = 1763 cm-1.
19F NMR: d = -54.8 (E)/-59.3 (Z) (10:90) (s, CF3).
1H NMR: d = 2.5 (Z)/3.0 (m, 4 H), 2.65 (m,4 H), 3.3 (Z)/3.7 (m, 4
3-(4-Fluorophenyl)-5-phenyl-1,1,1-trifluoropentan-2-one (16a)
19F NMR: d = -77.4 (s, CF3), -113.8 (m, C6H4F).
H), 6.9-7.8 (m,12 H).
1H NMR: d = 2.1 (m, 1 H), 2.5 (m, 3 H), 4.0 (t, J = 7.0 Hz, 1 H),
7.0-7.5 (m, 9 H).
13C NMR: d = 33.5/34.9 (Z), 36.0 (Z)/37.2, 51.1/51.9 (Z), 67.2 (Z)/
1
67.8, 123.9 (q, JC-F = 281 Hz, CF3), 125.8-128.6, 132.8, 133.2,
135.3 (q, 2JC-F = 29 Hz, CF3C=C), 138.1, 141.3, 143.8 (q, 3J C-F = 2.1
Hz, CF3C=C).
13C NMR: d = 32.9, 34.0, 51.3, 115.8 (q, 1JC-F = 293 Hz, CF3), 116.2
2
3
(d, JC-F = 22 Hz, CHCF), 126.4, 128.3, 128.6, 130.2 (d, JC-F = 8
4
1
Hz), 130.8 (d, JC-F = 4 Hz), 140.3, 162.5 (d, JC-F = 245 Hz, CF),
Anal. calcd for C25H24F3NO (411.5): C, 72.98; H, 5.88; N, 3.40.
Found: C, 72.82; H, 5.90; N, 3.30.
191.5 (q, 2JC-F = 31 Hz, CF3CO).
3-(4-Methoxyphenyl)-5-phenyl-1,1,1-trifluoropentan-2-one
(E,E/Z,E)-4-Morpholino-1-phenyl-3-(2-phenylethyl)-5,5,5-trif-
luoropenta-1,3-diene (13d)
(16b)
19F NMR: d = -76.9 (s, CF3).
19F NMR: d = -56.0 (Z,E)/-61.8 (E,E) (90:10) (s, CF3).
1H NMR: d = 2.1 (m, 1 H), 2.4 (m, 1 H), 2.5 (m, 2 H), 3.8 (s, 3 H,
OCH3), 3.95 (t, J = 7.0, 1 H), 6.9-7.5 (m, 9 H).
13C NMR: d = 33.0, 33.9, 51.4, 55.2, 114.7, 115.8 (q, 1JC-F = 293 Hz,
CF3), 126.3, 126.8, 128.4, 128.6, 129.8, 140.7, 159.6, 191. 5 (q,
2JC-F = 33 Hz, CF3CO).
1H NMR: d = 2.8 (m, 4 H, 2 CH2), 3.0 (m, 4 H, 2 CH2), 3.9 (t, J = 4.4
Hz, 4 H, 2 CH2), 6.9 (d, J = 16 Hz, 1 H), 7.1-7.6 (m, 10 H), 7.8 (d,
J = 16 Hz, 1 H).
13C NMR: d = 29.8 (Z,E)/30.8(E,E), 35.5(E,E)/36.4(Z,E),
50.9(E,E)/52.1(Z,E), 66.9(E,E)/67.8(Z,E), 124.7 (q, 1JC-F = 278 Hz,
CF3), 126.5, 127.0, 128.4, 128.7, 128.8, 129.0, 132.6, 132.9, 134.7
Synthesis 2000, No. 6, 838–842 ISSN 0039-7881 © Thieme Stuttgart · New York